Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head,

Personalis, Inc. PSNL, a leader in advanced genomics for cancer, today announced the appointment of Christopher Hall as SVP and Head, Diagnostics Business. As part of the executive leadership team, Hall will drive the vision and strategy for commercializing Personalis' diagnostic product offerings.

We are excited to welcome Chris given his immense experience in successfully scaling diagnostics businesses, said John West, CEO of Personalis. He is a great fit for Personalis as we expand into the clinical market. His track record is impressive from CEO of a health technology start-up focused on multi-omics, to prior roles including leading Veracyte's commercial organization, launching its products, and growing the business to nearly $100 million in diagnostic revenue.

Hall brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health, Inc. Previously, he served as President, COO, and Chief Commercial Officer at Veracyte, Inc., where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Hall also served as SVP and Chief Business Officer at Berkeley HeartLab, Inc. (part of Celera Corporation), where he helped a new product launch and restructured operations to improve profitability and streamline delivery of services.